Celebrate Lung Cancer Awareness Month

Every fall, the lung cancer community gathers to raise awareness for this disease and stand together – unified and strong. November is Lung Cancer Awareness Month – a time to come together to celebrate the strength of the lung cancer community. A great way to get involved in raising awareness about lung cancer is by joining us on Saturday, November 5 for our nationwide walk - Breathe Deep TOGETHER presented by Amgen. Thousands of people from across the country, coming together in a singular event, is a great way to make our voices heard and increase the visibility of lung cancer. In-person

Get the Answers You Need

Whether you are newly diagnosed or a long-term survivor, LUNGevity offers lung cancer support and survivorship services to address your unique needs. LUNGevity's services are designed to help you feel supported, informed, and empowered to be an active decision-maker in your treatment process and live well with the disease. LUNGevity's survivorship services are free and feature programs for survivors, caregivers, and family members. Read on to learn about our offerings and how you can access the services that are right for you. The Lung Cancer HELPLine The Lung Cancer HELPLine, in partnership

World Lung Cancer Day and the Changing Landscape of Lung Cancer

For decades, lung cancer was synonymous with low survival rates, limited treatment options, and poor quality of life for those living with the disease. Each year, more than 236,000 people in the US are diagnosed with lung cancer. The high incidence of lung cancer means scientific research into new therapies is critical, both for current survivors and those who will be diagnosed in the future. Thankfully, the landscape of lung cancer is changing for the better. Due to progress in research and drug development, there are more treatments and hope for the lung cancer community than ever before

Facebook Live: A Conversation with the EGFR Resisters Patient Group

Upal Basu Roy, PhD, MPH, LUNGevity's Executive Director of Research, chats with Jill Feldman and Ivy Elkins, co-founders of the EGFR Resisters; and Drs. Christine Lovly, MD, PhD (Vanderbilt University) and Helena Yu, MD (Memorial Sloan Kettering), who received the 2021 EGFR Resisters/LUNGevity Foundation Awards. Hear first-hand from both patients and researchers about why this patient-driven partnership matters to the EGFR community.